Know What's Happening in Healthcare
Know What's Happening in Healthcare
FDA approves first CIRM‑funded gene‑editing therapy for rare immune disorder
The FDA has granted approval to KRESLADI, a gene‑editing therapy from Rocket Pharmaceuticals that treats severe leukocyte adhesion deficiency‑I in children without a matching bone‑marrow donor. It is the first product directly funded by California’s Institute for Regenerative Medicine (CIRM), highlighting the agency’s impact on translational research.
Also developing:
By the numbers: Syneron Bio raises $150M Series B
Ireland has unveiled a €1 million digital mental health strategy that outlines a national roadmap for digital tools, shared records and technology‑enabled services. The plan builds on the 2020‑2030 "Sharing the Vision" policy and prioritises the HSE Health App, a national shared care record, community care record and electronic health records. Core principles include co‑design with service users, robust standards, GDPR compliance and digital inclusion. Implementation will span apps, wearables, AI predictive modelling and a new data governance framework to improve accessibility and quality of mental health care.
Canary Speech has partnered with JubileeTV to embed its AI‑driven vocal‑biomarker technology into consumer video calls, marking the first deployment outside clinical settings. The system analyzes 40 seconds of natural conversation, extracting thousands of acoustic features to generate nondiagnostic scores...
TigerConnect unveiled a cloud‑native operator console aimed at replacing decades‑old hospital switchboards. The platform unifies call routing, code activations, and alarm management into a single dashboard while integrating with EHRs, telephony and scheduling tools. AI‑driven automation and intelligent search streamline...
At a recent round‑table, a speaker outlined how the NHS 10‑year plan can be accelerated by applying platform‑centric principles drawn from the Platformland framework. The presentation highlighted four pillars: digital ways of working, platform‑based clinical functions, converting the public into...
I just started testing a new continuous glucose monitor (CGM) device from Syai. I tried Abbott Freestyle Libre 2 and Sibionics before, but the need for the reader with Libre was a pain in the process, and the Sibionics app is...
Texas filed its antitrust suit against Epic Systems in state court to avoid federal consolidation and the stricter Twombly/Iqbal pleading standards. Epic’s motion to dismiss challenges the state’s market definition, arguing that the split between acute‑care and academic hospital EHR...
Kyndryl and the University of Liverpool’s Civic Health Innovation Labs have launched a partnership to apply Kyndryl’s Agentic AI Framework to co‑develop blueprints for next‑generation healthcare technologies. The first phase will generate conceptual AI projects, emphasizing conversational agents that help...
Maintenance of certification (MOC) for physicians varies dramatically across specialties and states, creating a fragmented, costly system with little evidence of patient‑outcome benefits. Boards under the ABMS set broad standards but allow autonomous, disparate requirements ranging from quarterly quizzes to...
Sciwind Biosciences granted Pfizer China exclusive rights to commercialize ecnoglutide injection in Mainland China. Sciwind will keep the marketing authorization and handle R&D, registration, manufacturing, and supply, receiving up to $495 million in milestone payments. Ecnoglutide, a cAMP‑biased GLP‑1 receptor agonist,...
Congress missed its Jan. 30 deadline to extend ACA subsidies, leaving roughly four million Americans without financial assistance and prompting a surge in uninsured individuals. The lapse underscores a broader health‑care cost crisis that has become a flashpoint ahead of the...
Researchers at Sultan Qaboos University have isolated three antimicrobial peptides from dromedary camels, with CdPG-3 and CdCATH showing potent activity against methicillin‑resistant Staphylococcus aureus and multidrug‑resistant Escherichia coli. The peptides kill bacteria by disrupting their membranes while exhibiting low toxicity...
The Guardian profiles Ukraine’s first psychological trauma centre, Forest Glade, where soldiers like 25‑year‑old Kyrylo Chuvak undergo intensive three‑week rehabilitation after years of Russian captivity. The programme blends conventional therapy with unconventional activities such as tango, archery and guided breathing to...
A Harvard study published in Nature Communications reports that U.S. residents living closer to operational nuclear power plants face higher cancer mortality rates. The analysis covered mortality data from every county between 2000 and 2018 and adjusted for smoking, BMI,...
MiraDx has launched PROSTOX Standard, a clinically validated genetic test that predicts long‑term urinary toxicity for prostate cancer patients receiving conventional or moderately hypofractionated radiation therapy. The test uses a cheek swab and returns results in five to seven days,...
North Korean state‑backed Lazarus group has been linked to recent Medusa ransomware attacks targeting U.S. healthcare providers. Symantec’s report identifies a Lazarus sub‑unit, possibly Andariel/Stonefly, using the Medusa RaaS platform, which has affected more than 380 organizations since its 2021...
Immuto’s CEO Faraz Choudhury explains that conventional target discovery, which focuses on gene mutations and protein abundance, overlooks disease‑specific protein conformations. The company’s platform maps surface protein conformations (SPCs) in living, patient‑derived models using high‑resolution mass spectrometry and AI‑driven analysis,...
Orthonika, an Imperial College London spin‑out, received FDA Breakthrough Device Designation for its synthetic Total Meniscus Replacement (TMR) implant and an invitation to the Total Product Life Cycle Advisory Program. The designation promises prioritized regulatory engagement, speeding the path to...
Beren Therapeutics announced that the U.S. Food and Drug Administration has accepted its New Drug Application for adrabetadex, an investigational therapy aimed at treating infantile‑onset Niemann‑Pick disease type C (NPC). The agency set a target action date of 17 August 2026 under the...
The future of medicine might be something you swallow. When I first read about PillBot, I paused. A tiny ingestible robot camera that replaces traditional endoscopies? That is not incremental innovation. That is a shift. Instead of invasive tubes and hospital procedures,...
Epredia and Mindpeak have signed a distribution agreement to bring Mindpeak’s AI‑driven image‑recognition software to Epredia’s European digital pathology customers. The AI modules deliver pixel‑level analysis for breast, lung, gastrointestinal cancers and biomarker quantification, operating without cloud connectivity to preserve...
A new combination‑therapy approach for inflammatory bowel disease (IBD) aims to boost remission rates beyond the current 30 % success benchmark. By pairing agents that target distinct immune pathways, early trials show remission climbing to roughly 55 % and faster mucosal healing....
A forthcoming Pediatric Research review by Vimalesvaran and Dhawan examines the current state of Metabolic Dysfunction‑associated Steatotic Liver Disease (MASLD) screening in children, highlighting advances in imaging and biomarker research while exposing persistent gaps in sensitivity and guideline standardization. The...
GSMA Foundry has signed a strategic partnership with Singapore’s National University Health System (NUHS) to accelerate 5G‑enabled, AI‑driven healthcare solutions. The collaboration will leverage private 5G networks, digital twins, XR, IoT and ambient AI to enable remote surgical assistance, immersive...
Researchers published a comparative analysis of replicative versus chemically‑induced senescence in articular chondrocytes, revealing divergent molecular signatures, secretory profiles, and mitochondrial dynamics. Replicative senescence displayed a controlled, anti‑inflammatory SASP and stable epigenetic marks, while chemically‑induced senescence produced a pro‑inflammatory secretome,...
b.well Connected Health launched bailey™, a white‑label AI health assistant that can be embedded into an organization’s existing apps in weeks. Powered by b.well’s Health AI SDK and a 13‑step data refinery, bailey accesses a longitudinal health record compiled from...
MENA CIOs are drawing firm lines around AI sovereignty, keeping regulated workloads—such as patient data, identity systems, and core financial transactions—on sovereign or on‑premise infrastructure while leveraging hyperscalers for development, testing, and non‑sensitive analytics. The hybrid approach reflects regional regulatory...
UCLA Health researchers published a JAMA Internal Medicine study showing that dry powder inhalers (DPIs) and soft‑mist inhalers (SMIs) cut COPD exacerbations while eliminating high‑global‑warming‑potential propellants used in metered‑dose inhalers (MDIs). The analysis of insurance‑claims data from 2016‑2025 found a...
Hims & Hers disclosed its fourth‑quarter earnings and announced that it has withdrawn the controversial GLP‑1 weight‑loss pill it briefly launched. The decision followed conversations with key ecosystem stakeholders, including regulators and partner pharmacies. The company highlighted modest revenue growth...
InnoScot Health has launched a call for early‑stage innovators—including final‑year trainees, first‑year practitioners, SMEs and student entrepreneurs—to submit ideas that improve patient care, efficiency, workforce wellbeing, or enable data‑driven remote care. Successful applicants will receive a support package covering intellectual‑property...
Allurion received FDA clearance for its Gastric Balloon System featuring the Smart Capsule, a swallow‑able, endoscopy‑free obesity treatment. The capsule is placed during a 15‑minute office visit, inflates in the stomach for about four months, then exits naturally, with a...
Magnetic hydrogel microrobots (MHMs) are emerging untethered soft robots that combine magnetic actuation with responsive hydrogel matrices. Recent research highlights dual design strategies that integrate material optimization and functional integration, enabling precise, spatiotemporal control. Innovations in bionic structures and multimodal...
CMS released its 2026 Merit‑based Incentive Payment System updates, adding administrative claims scoring, a TEFCA participation bonus, and a new AI safety measure. The changes affect quality, interoperability, improvement activities, and cost categories, with retroactive application to 2025 for large...
A new NIH‑backed assessment of targeted HIV prevention and harm‑reduction services in five major U.S. cities shows a 15% decline in new infections over the past year. The study attributes the drop to expanded syringe‑exchange programs, mobile testing units, and...
Oncology drug waste reaches up to 30%, costing over $2 billion annually in the U.S. A 2023 CMS rule now forces manufacturers to refund Medicare for discarded volumes beyond a 10% threshold, adding financial pressure. Traditional forecasting relies on static sales...
Finn Stevenson, CEO of AI‑driven physiotherapy startup Flok Health, discussed on the UKTN Podcast how slow reform in the NHS hampers patient care, especially for back‑pain sufferers. He highlighted Flok's hybrid model that combines algorithmic triage with live physiotherapist sessions...
The world’s largest health-focused AI app is from China now, with over 100 million (!) users. Ant Group just released this number and more details of what their plans are with the app. "Among its new users, 52% came from third-tier cities...
Slate starts up with $130M and a headache drug from China https://t.co/6DEltQAI8s by @gwendolynawu #biotech #startups $HLUBF
Radiopharmaceutical manufacturers must design ultra‑fast supply chains because isotopes decay rapidly, turning each dose into a ticking clock. Companies such as NorthStar and Nucleus mitigate this by locating production near major airports, using private air freight for longer‑half‑life isotopes, and...
Emerging synthetic opioid cychlorphine, up to ten times more potent than fentanyl, has been linked to fatal overdoses across the United States, Canada, the United Kingdom, France, and Germany. Tennessee alone reports 19 deaths under investigation, with 12 confirmed, while...
Ambience Healthcare was named the 2026 KLAS/CHIME Trailblazer Award winner, recognizing its leadership in AI‑driven clinical documentation and revenue integrity. The award, now in its second year, evaluates vendors on KLAS performance scores, client feedback, and measurable industry impact. Ambience’s...
Researchers at EPFL have created a drug‑controlled CAR‑T platform called DROP‑CAR that can be turned off on demand with the FDA‑approved BCL‑2 inhibitor venetoclax. The system places a reversible protein‑protein interaction on the cell surface, causing the CAR to dissociate...
The UK government will add a £3,000 average annual bonus to GP contracts for prescribing the weight‑loss drug Mounjaro, plus a £1,000 incentive for referrals to weight‑loss programmes, starting in April 2026. The scheme targets patients who meet current NHS...
Flatiron Health showcased its global Prostate and Bladder Cancer Panoramic datasets at the ASCO GU 2026 symposium, leveraging over 420,000 longitudinal patient records from the US, UK and Germany. Six research presentations highlighted critical gaps in genetic testing, equitable access...
UC Davis engineers unveiled VESSEL, a cell‑free platform that produces extracellular vesicles bearing a single surface protein. By isolating individual proteins, the system enables direct functional mapping, exemplified by the discovery that CADM1 promotes vesicle uptake. The approach is scalable...
Cytokinetics announced rapid global regulatory clearance for MYCorzo, securing FDA, China NMPA, and European Commission approvals within a single week. The company launched the drug in the U.S. with over 700 REMS‑certified physicians and more than 12,000 customer engagements in...
Orthofix Medical reported fourth‑quarter 2020 net sales of $118 million, a 3% decline year‑over‑year but a 6% sequential increase. Spine implant revenue grew 9% YoY, propelled by an 11% rise in U.S. M6 disc sales, while motion‑preservation revenue jumped 129% YoY....
Harmony Biosciences reported $714.7 million net product revenue for 2024, a 23% year‑over‑year increase, with Q4 sales of $201.3 million driven largely by its flagship narcolepsy drug Wakix. The company announced a generic settlement with Novogen that postpones competition until at least...
Globus Medical reported a record $2.519 billion revenue for 2024, up 61% year‑over‑year, and a non‑GAAP EPS of $3.04, a 31% increase. Free cash flow surged 145% to $405 million, allowing the company to eliminate its remaining $1 billion merger debt by Q1 2025....
Evolent Health reported $2.55 billion in 2024 revenue, a 30% year‑over‑year increase, with adjusted EBITDA of $160.5 million landing at the low end of its guidance due to elevated oncology costs. The company announced two major contracts—a New England health plan covering...
Ceribell reported a 34% year‑over‑year revenue increase to $24.8 million in Q4 2025, reaching $89.1 million for the full year. Gross margins remained high at 87% for the quarter, with a cash balance of $159.3 million, while net loss widened to $13.5 million due...
